(Q33685866)

28 July 2017

1 reference

title

Is psychotherapy an effective treatment for melancholia and other severe depressive states? (English)

1 reference

28 July 2017

1 reference

1 reference

Thase ME

1

1 reference

PubMed ID

10403142

28 July 2017

Friedman ES

series ordinal

2

1 reference

28 July 2017

1 July 1999

1 reference

Journal of Affective Disorders

28 July 2017

1 reference

28 July 2017

54

1 reference

28 July 2017

1-2

1 reference

28 July 2017

1-19

1 reference

Characterological depressions. Clinical and sleep EEG findings separating 'subaffective dysthymias' from 'character spectrum disorders'

28 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Cluster analysis and the classification of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Hypercortisolemia and hippocampal changes in depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocortical system?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

An Inventory for Measuring Depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Treatment of depression with cognitive therapy and amitriptyline

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Prediction of tricyclic antidepressant response: a critical review

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

The efficacy of cognitive therapy in depression: a treatment trial using cognitive therapy and pharmacotherapy, each alone and in combination

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Controlled acute and follow-up trial of cognitive therapy and pharmacotherapy in out-patients with recurrent depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

The classification of depression through cluster analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Minute-by-minute analysis of REM sleep timing in major depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Diagnostic and research applications of electroencephalographic sleep studies in depression. Conceptual and methodological issues

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Depression and the Newcastle Scales Their Relationship to Hamilton's Scale

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

THE DIAGNOSIS OF DEPRESSIVE SYNDROMES AND THE PREDICTION OF E.C.T. RESPONSE.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

The focus of therapist interventions in cognitive therapy for depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

A double-blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholia. The Venlafaxine French Inpatient Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. Danish University Antidepressant Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Determinants of change in cognitive therapy for depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

A control group for psychotherapy research in acute depression: One solution to ethical and methodologic issues

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Functional neuroimaging studies of depression: the anatomy of melancholia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Initial severity and differential treatment outcome in the National Institute of Mental Health Treatment of Depression Collaborative Research Program

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

National Institute of Mental Health Treatment of Depression Collaborative Research Program

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Separation of subtypes of depression using discriminant analysis. I. Separation of unipolar endogenous depression from non-endogenous depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Biological 'markers' for endogenous depression. Effect of age, severity of illness, weight loss, and polarity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Distraction in neurotic and endogenous depression: an investigation of negative thinking in major depressive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Biological and psychological processes in the treatment and maintenance of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Dexamethasone suppression tests in antidepressant treatment of melancholia. The process of normalization and test-retest reproducibility

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Cognitive Therapy and Pharmacotherapy for Depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Short-Term Psychotherapy of Depressive Disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Does the pretreatment polysomnogram predict response to cognitive therapy in depressed outpatients? A preliminary report.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Predictors of drug response in depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Relationship of cortisol hypersecretion to brain CT scan alterations in depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Endogenomorphic depression. A conceptual and terminological revision

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Depressed outpatients treated with cognitive therapy or pharmacotherapy. A one-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Two roads to rapid eye movement latency

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

1 reference

7 January 2021

Treatment of depressive symptoms in human immunodeficiency virus-positive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Severity of depression and hypothalamic-pituitary-adrenal axis dysregulation: identification of contributing factors.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

The nosology of depression: the endogenous-reactive concept

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Cognitive therapy and pharmacotherapy. Singly and together in the treatment of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Characteristics of autonomous depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Endogenous depression as a construct: a quantitative analysis of the literature and a study of clinician judgements

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Prognosis of depression and the endogenous-neurotic distinction

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

The role of psychotherapy in the treatment of depression: review of two practice guidelines.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Research diagnostic criteria subtypes of depression. Their role as predictors of differential response to psychotherapy and drug treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Sleep deprivation as a probe in the elderly.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

The DST as a predictor of outcome in depression: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Treatment of adolescents with major depression: implications of the DST and the melancholic clinical subtype

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Cortisol hypersecretion and cognitive impairment in depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Comparative efficacy of cognitive therapy and pharmacotherapy in the treatment of depressed outpatients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Polysomnographic findings in recently drug-free and clinically remitted depressed patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Reduced REM latency predicts response to tricyclic medication in depressed outpatients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Melancholic symptom features and DSM-IV.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Dexamethasone response, thyrotropin-releasing hormone stimulation, rapid eye movement latency, and subtypes of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Hypercortisolism and its possible neural bases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Edinburgh primary care depression study: treatment outcome, patient satisfaction, and cost after 16 weeks

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

The effectiveness of psychotherapy. The Consumer Reports study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Personality disorders and treatment outcome in the NIMH Treatment of Depression Collaborative Research Program

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Patient predictors of response to psychotherapy and pharmacotherapy: findings in the NIMH Treatment of Depression Collaborative Research Program

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Research diagnostic criteria: rationale and reliability

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Atypical features and treatment response in the National Institute of Mental Health Treatment of Depression Collaborative Research Program.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Duration of REM sleep latency as predictor of effect of antidepressant therapy. A preliminary report.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Cognitive Therapy for Major Depressive Disorder in Primary Care

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Validation of a Hamilton subscale for endogenomorphic depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Social skills training and endogenous depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Electroencephalographic sleep in psychotic depression. A valid subtype?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Severity of depression and response to cognitive behavior therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Relapse after cognitive behavior therapy of depression: potential implications for longer courses of treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Do depressed men and women respond similarly to cognitive behavior therapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Polysomnographic studies of unmedicated depressed men before and after cognitive behavioral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Abnormal electroencephalographic sleep profiles in major depression: association with response to cognitive behavior therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Identifying an abnormal electroencephalographic sleep profile to characterize major depressive disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Treatment of major depression with psychotherapy or psychotherapy-pharmacotherapy combinations

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Which depressed patients will respond to interpersonal psychotherapy? The role of abnormal EEG sleep profiles

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Electroencephalographic sleep profiles before and after cognitive behavior therapy of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Effects of iproniazid in depressive syndromes.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Melancholia: from DSM-III to DSM-III-R.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Coping styles, homework compliance, and the effectiveness of cognitive-behavioral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Preventing hung juries about therapy studies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Affect intensity and phasic REM sleep in depressed men before and after treatment with cognitive-behavioral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

Biological markers, treatment outcome, and 1-year follow-up in endogenous depression: electroencephalographic sleep studies and response to cognitive therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2899%2900033-6

7 January 2021

10.1016/S0165-0327(99)00033-6

Identifiers

DOI

1 reference

28 July 2017

1 reference

PubMed ID

10403142